Top 5 Health Care VC Funds & Investors in Cayman Islands (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Longpan Investment
VC Fund
|
2 | China, United States, Cayman Islands | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $14M–$60M |
|
Delian Capital
VC Fund
|
2 | China, United States, France | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $1.5M–$50M |
|
Apricot Capital
VC Fund
|
1 | United States, China, Malaysia | Seed, Series A | Health Care, Biotechnology, Advertising | $1M–$10M |
|
RiverHead Capital
VC Fund
|
1 | China, United States, Cayman Islands | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.4M–$283M |
|
Corvus Capital
VC Fund
|
1 | Cayman Islands | Seed | Medical, Health Care, Artificial Intelligence | |
| Access all 16 VC funds in Cayman Islands Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Longpan Investment is an investment firm.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Cayman Islands
Investor stats
- Total investments: 40
- Round size: Seed $14M–$60M; Series A $14M–$30M; Series B $14M–$37M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Bodie Hekang — Bodie Hekang is a biopharmaceutical services company dedicated to advancing therapies for autoimmune and inflammatory diseases. Combining translational research, preclinical development, and clinical support, the company specializes in engineering and developing regulatory T cell (Treg) immunotherapies designed to restore immune tolerance andreduce pathological inflammation. Bodie Hekang partners with academic institutions, biotech firms, and pharmaceutical companies to provide end-to-end services that include target validation, cell manufacturing process development, potency and safety testing, and regulatory strategy support. Its multidisciplinary team of immunologists, cell biologists, and clinical development experts focuses on innovative approaches to enhance Treg stability, specificity, and functionality, aiming to translate promising laboratory findings into scalable, clinically viable treatments for conditions such as rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus.
- Qinghui Liannuo — Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory andrecurrent solid tumors and hematomas.
- Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: China, United States, France
Investor stats
- Total investments: 97
- Round size: Seed $1.5M–$50M; Series A $1.6M–$17M; Series B $9.9M–$29M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
- Genrobot.ai — Genrobot.ai develops AI-powered robots for automation, data analysis, and intelligent task management across industries.
- Gnosis Healthineer — Gnosis Healthineer provides medical devices to hospitals such as Clinical EEG AI Model. It builds an EEG data center for second- and third-level general hospitals to solve the problem of insufficient EEG data storage. The hardware construction of the data center includes: PB-level storage and servers, and high-performance computing equipment.
Apricot Capital is a seed stage investment firm based in Boston, MA and Toronto, Canada. Investments: awe.sm, Careport Health, Clypd, Crashlytics (acquired 2012), Habit Labs, Kinvey, Massive Damage, Momentfeed, MyTime, OnSwipe, Placester, Smart Lunches, TribeHR (acquired 2013), Peekaboo Mobile (acquired 2011)
Show more...Investment focus
- Industry: Health Care, Biotechnology, Advertising
- Stage:Seed, Series A
- Geography: United States, China, Malaysia
Investor stats
- Total investments: 10
- Round size: Seed $1M–$10M; Series A $1.2M–$3.2M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Kind Kones — We deliver plant-based ice cream and wholesome treats!
- D2M Biotherapeutics — D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.
- ClinChoice — Fountain Medical Development Ltd., a contract research organization, provides ICH GCP compliant clinical research services for the multinational clients in China and the United States. It offers consulting, project management, regulatory affairs, clinical operations, central laboratory services, site management, biometrics, and clinical trialdesigns, as well as AE/SAE collection, review, assessment and reporting services, data and safety monitoring board handling, and signal detection services. The company is based in Beijing, China.
River Head Capital is the private equity arm of the Sunshine Insurance Group.River Head Capital was established in January 2015. It is the first batch of insurance private fund pilot units approved by the China Insurance Regulatory Commission. The fund management scale has reached 17 billion yuan.Adhering to the corporate vision of “making lifebetter”, with the mission of “creating value, trustworthiness, investing resources in the most valuable companies, and gaining the trust of investors with excellent returns”, the company will actively deploy medical health and emerging Industries, emerging consumption, industrial mergers and acquisitions, real estate and other fields, through entrepreneurial support, strategic investment, financial investment, mergers and acquisitions, corporate restructuring, cross-border investment and other diversified ways to invest in enterprises, comprehensively enhance corporate value and support the healthy and sustainable development of enterprises. At present, River Head Capital has invested in a number of companies in the fields of medical, pharmaceutical, Internet, and innovative financial services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, Cayman Islands
Investor stats
- Total investments: 40
- Round size: Series A $1.4M–$74M; Series B $14M–$283M; Series C $15M–$43M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Layerwave Bio — Layerwave Bio is a developer of IVD diagnostic instrument reagents and biomedical scientific research instruments.
- Startorus Fusion — Startorus Fusion focuses on developing and commercializing fusion energy technologies, aiming for controllable device miniaturization, commercialization, and fast iteration, integrating design, R&D, operation, and maintenance.
- Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Corvus Capital is a venture capital and private equity firm that provides growth investments in buyout transactions.
Show more...Investment focus
- Industry: Medical, Health Care, Artificial Intelligence
- Stage:Seed
- Geography: Cayman Islands
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Sarborg — Sarborg is an artificial intelligence company that provides solutions with cybernetics and machine learning for pharmaceutical sector.
Health Care VC funding in Cayman Islands at a glance
Stats across 13 deals from 16 investors.
Access all 16 VC funds in Cayman Islands Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Cayman Islands investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 16 VC funds investing in Cayman Islands Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
